Fexuprazan

DB16078InvestigationalSmall molecule

Abeprazan is under investigation in clinical trial NCT04341454 (Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis).

Chemical structure of Fexuprazan
Mechanism
Curator reviewed
Formula / weight
C19H17F3N2O3S · 410.41 g/mol (avg)
Also known as
1H-PYRROLE-3-METHANAMINE, 5-(2,4-DIFLUOROPHENYL)-1-((3-FLUOROPHENYL)SULFONYL)-4-METHOXY-N-METHYL- · 5-(2,4-DIFLUOROPHENYL)-1-((3-FLUOROPHENYL)SULFONYL)-4-METHOXY-N-METHYL-1H-PYRROLE-3-METHANAMINE · Abeprazan
Code names
DWP-14012

Resolves to

Compound
UNIIBE52S2C1QTCAS1902954-60-2ChEMBLCHEMBL4594445ChEBI757930PubChem122662112
Clinical / RWD
ATCA02BC10
Structure
InChIKeyOUNXGNDVWVPCOL-UHFFFAOYSA-NSMILESCNCC1=CN(C(=C1OC)C1=C(F)C=C(F)C=C1)S(=O)(=O)C1=CC(F)=CC=C1
Targets
P20648ATP4A

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
29Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 6 drug categories
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Fexuprazan, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In